Asami Y, Ishiguro H, Ueda A, Nakajima H: First report of membranous nephropathy and systemic lupus erythematosus associated with abatacept in rheumatoid arthritis. Clin Exp Rheumatol, 34(6): 1122, 2016.
Furukawa H, Oka S, Kawasaki A, Shimada K, Sugii S, Matsushita T, Hashimoto A, Komiya A ,Fukui N, Kobayashi K,Osada A, Ihata A, Kondo Y, Nagai T, Setoguchi K, Okamoto A, Chiba N, Suematsu E,Kono H, Katayama M, Hirohata S, Sumida T, Migita K, Hasegawa M, Fujimoto M, Sato S, Nagaoka S, Takehara K, Tohma S, Tsuchiya N: Human leukocyte antigen and systemic sclerosis in Japanese:The sign of four independent protective alleles, DRB1*13:02, DRB1*14:06 DQB1*03:01, DPB1*02:01.
PLoS One,11(4):e154255, 2016.
Hachiya Y, Kawasaki A, Oka S,Kondo Y, Ito S,MatsumotoI, Kusaoi M, Amano H, Suda A, Setoguchi K, Nagai T, Shimada K, Sugii S, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Kono H, Hirohata S, Takasaki Y, Hashimoto H, Sumida T, Nagaoka S, Tohma S, Furukawa H, Tsuchiya N: Association of HLA-G3’Untranslated region polymorphisms with systemic lupus erythematosus in a Japanese population:A case-control association study. PLoS One,11(6):e0158065, 2016.
Hirano F, Yokoyama W, Yamazaki H, Amano K, Kawakami A, Hayashi T, Tamura N, Yasuda S, Dobashi H, Fujii T, Ito S, Kaneko Y, Matsui T, Okuda Y, Saito K, Suzuki F, Yoshimi R, Sakai R, Koike R, Kohsaka H, Miyasaka N, Harigai M: Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategy. Mod Rheumatol,1-9.2016.
Ikeda K, Narita A, Ogasawara M, Ohno S, Kawahito Y, Kawakami A, Ito H, Matsushita I, Suzuki T, Misaki K, Ogura T, Kamishima T, Seto Y, Nakahara R, Kaneko A, Nakamura T, Henmi M, Fukae J, Nishida K, Sumida T, Koike T：Consensus-based identification of factors related to false-positives in ultrasound scanning of synovitis and tenosynovitis. Mod Rheumatol,9-14, 2016.
Izumi Y, Akazawa M, Akeda Y, Tohma S, Hirano F, Ideguchi H, Matsumura R, Miyamura T, Mori S, Fukui T, Iwanaga N, Jiuchi Y, Kozuru H, Tsutani H, Saisyo K, Sugiyama T, Suenaga Y, Okada Y, Katayama M, Ichikawa K, Furukawa H, Kawakami K, Oishi K, Migita K. The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial. Arthritis Res Ther, 19(1):15, 2017.
Kirino Y, Ideguchi H, Takeno M, Suda A, Higashitani K, Kunishita Y, Takase-Minegishi K, Tamura M, Watanabe T, Asami Y, Uehara T, Yoshimi R, Yamazaki T, Sekiguchi A, Ihata A, Ohno S, Ueda A, Igarashi T, Nagaoka S, Ishigatsubo Y, Nakajima H: Continuous evolution of clinical phenotype in 578 Japanese patients with Behcet’s disease: a retrospective observational study. Arthritis Res Ther, 18: 217, 2016.
Kunishita Y, Yoshimi R, Takeno M, Yamanaka S, Sugiyama Y, Tsuchida N, Kishimoto D, Kamiyama R, Minegishi K, Hama M, Kirino Y, Ishigatsubo Y, Ueda A, Nakajima H: Non-IgG4-related Multifocal Fibrosclerosis. Intern Med, 55: 2497-502, 2016.
Oka S, Furukawa H, Shimada K, Sugii S, Hashimoto A,Fukui N, Suda A,Tsunoda S, Itoh S, Katayama M,Nakamura T, Saisho K、Sano H, Migita K, Nagaoka S, Tsuchiya N, Tohma S: Association of human leukocyte antigen alleles with chronic lung diseases in rheumatoid arthritis. Rheumatology (Oxford), 55(7):1301-1307, 2016.
Takeuchi M, Ombrello MJ, Kirino Y, Erer B, Tugal-Tutkun I, Seyahi E, Ozyazgan Y, Watts NR, Gul A, Kastner DL, Remmers EF. A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behcet’s disease in HLA-B*51 carriers. Ann Rheum Dis, 75: 2208-11, 2016.
Toyota Y, Tamura M, Kirino Y, Sugiyama Y, Tsuchida N, Kunishita Y, Kishimoto D, Kamiyama R, Miura Y, Minegishi K, Yoshimi R, Ueda A, Nakajima H. Musculoskeletal ultrasonography delineates ankle symptoms in rheumatoid arthritis. Mod Rheumatol, 1-5, 2016.
Uehara T, Takeno M, Hama M, Yoshimi R, Suda A, Ihata A, Ueda A, Tateishi U, Ishigatsubo Y: Deep-inspiration breath-hold 18F-FDG-PET/CT is useful for assessment of connective tissue disease associated interstitial pneumonia. Mod Rheumatol, 26(1):121-127, 2016.
Watanabe T, Takase-Minegishi K, Ihata A, Kunishita Y, Kishimoto D, Kamiyama R, Hama M, Yoshimi R, Kirino Y, Asami Y, Suda A, Ohno S, Tateishi U, Ueda A, Takeno M, Ishigatsubo Y: (18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis. Mod Rheumatol, 26(2): 180-7, 2016.
Yamanaka H, Nagaoka S, Lee SK, Bae SC, Kasama T, Kobayashi H, Nishioka Y, Ueki Y, Seto Y, Nishinarita M, Tamura N, Kimura N, Saito K, Tomita T, Nawata Y, Suzuki S, Ishigatsubo Y, Munakata Y, Makino Y, Inoue E, Tanaka Y, Takeuchi T: Discontinuation of Etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity-results from ENCOURAGE STUDY. a prospective, international, muticenter randomized study. Mod Rheumatol,26(5):651-661, 2016.
Yoshimi R, Takeno M, Toyota Y, Tsuchida N, Sugiyama Y, Kunishita Y, Kishimoto D, Kamiyama R, Minegishi K, Hama M, Kirino Y, Ishigatsubo Y, Ohno S, Ueda A, Nakajima H: On-demand ultrasonography assessment in the most symptomatic joint supports the 8-joint score system for management of rheumatoid arthritis patients. Mod Rheumatol, 13: 1-9, 2016.
